Working… Menu

A Trial of KB004 in Patients With Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03374943
Recruitment Status : Active, not recruiting
First Posted : December 15, 2017
Last Update Posted : December 9, 2020
Humanigen, Inc.
Information provided by (Responsible Party):
Olivia Newton-John Cancer Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 22, 2021
Estimated Study Completion Date : April 22, 2021